Back to search

University of Strathclyde

Investigating the immunomodulatory effects of Non-Ionic Surfactant Vesicles to combat viral sepsis

Abstract

dc:description.abstract

Current anti-inflammatory therapies often utilise a single mechanism of action and come witha range of side-effects that reduce the scope of therapeutic applications. One such therapyis the conventional corticosteroid, dexamethasone used to treat the hyperinflammatoryresponse-induced sepsis associated with severe SARS-CoV-2 infection. This drug hasdisplayed poor efficacy in early stages of SARS-CoV-2 infection, alongside side effects suchas weight gain, mood changes, vision impairment, osteoporosis, and poor glycaemic controlin diabetic patients - a cohort at greater risk of death from SARS-CoV-2 infection. Herein, Iexplore Non-Ionic Surfactant Vesicles (NISV) as an immunomodulatory therapy for thetreatment of viral infection induced sepsis. I compare NISV and dexamethasone byexamining modulation of cytokine production in TLR7 and TLR8 stimulated bone marrowderived macrophages (BMDM) using ELISA and Cytometric bead array, alongsidetranscriptomic and metabolomic analyses. I also investigate NISV size as a factor in theirimmunomodulatory effects. I demonstrate that whilst dexamethasone displays broadimmunosuppression of cytokines regardless of TLR stimulation, NISV differentially modulatecytokine production dependent on specific TLR activation. This effect is generally retained asNISV size decreases, with a small increase in potency. Whilst NISV effects on energymetabolism are minor, I observe an increase in phospholipid synthesis and regulation of theanti-inflammatory TCA cycle metabolite itaconate in treated cells. Finally, I demonstrate thatwhilst both NISV and dexamethasone downregulate NF-kB activation, NISV also controlinflammation through downregulation of the non-canonical NLRP3 inflammasome. Here, Ibroadly present NISV as an immunomodulatory therapy that can transcriptionally regulateinflammation-associated gene expression through multiple regulatory pathways in a way thatdexamethasone cannot. These results support further investigation of NISV as analternative anti-inflammatory to widely used corticosteroids during virally induced sepsis.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral-pg
Grantor dc:publisher.institution
University of Strathclyde
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • MacKie, Logan
Advisor dc:contributor.advisor
  • Roberts, Craig
Author Identifier dc:creator.authoridentifier
  • 202061198

Rights

Identifiers

dc:identifier.*
Identifier
T16893

Chain of custody

source
Harvested from
University of Strathclyde
Base URL
stax.strath.ac.uk/catalog/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

MacKie, Logan. Investigating the immunomodulatory effects of Non-Ionic Surfactant Vesicles to combat viral sepsis. doctoral-pg thesis, University of Strathclyde, 2024. https://stax.strath.ac.uk/concern/theses/xp68kg880